Skip to content
healthcare.dev

Duloxetine Delayed-Release

NDC 71610-736, DULOXETINE HYDROCHLORIDE, capsule, delayed release pellets, from Aphena Pharma Solutions - Tennessee, LLC.

Product NDC
71610-736
Status
Listed
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
CAPSULE, DELAYED RELEASE PELLETS
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203088
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71610-736 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DULOXETINE HYDROCHLORIDE30 mg/1

Pharmacologic classes

Norepinephrine Uptake Inhibitors [MoA]; Serotonin Uptake Inhibitors [MoA]; Serotonin and Norepinephrine Reuptake Inhibitor [EPC]

Package NDCNDC-11Package
71610-736-42716100736421800 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (71610-736-42)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/dcfd62c7-1687-4e9b-9ae4-5a44929ac765

Use it

Look up 71610-736 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71610-736 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71610-736. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.